A measure to aid in the interpretation of published clinical trials

Statistics in Medicine

Volumn 4, Issue 1, 1985, Pages 1-9

  Begg, Colin B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Clinical trials; Publication bias

Indexed keywords

BIAS; CLINICAL TRIAL; CONTROLLED STUDY; INTERPRETATION; METHODOLOGY; NONBIOLOGICAL MODEL; NONHUMAN;

ATTITUDE; CLINICAL TRIALS; HUMAN; MODELS, THEORETICAL; PUBLISHING; RANDOM ALLOCATION; STATISTICS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021960027     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4780040103     Document Type: Article

References (28)

1. Randomized clinical trials: perspectives on some recent ideas
2. Editorial: randomized clinical trials and the doctor‐patient relationship: an ethical dilemma
3. Nonrandomized controls in cancer clinical trials
4. Sensitivity and specificity of clinical trials: randomized vs. historical controls
5. Do retrospective controls make clinical trials “inherently fallacious”
6. A critical comparison of allogenic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocyte leukemia
7. Bayes methods for combining results of cancer studies in humans and other species
8. Reporting on methods in clinical trials
9. The delta and epsilon errors in the assessment of cancer clinical trials
10. Randomized clinical trials and research strategy
11. Strategy and alternate randomized designs in cancer clinical trials
12. Historical controls, data banks, and randomized clinical trials in clinical research a review
13. The “file drawer problem” and tolerance for null results
14. 2 tests
15. Combining results of independent studies
16. The design of a clinical trial with several patient categories
17. A Bayesian approach to subgroup analysis
18. The combination of randomized and historical controls in clinical trials
19. Long‐term disease‐free survival in acute nonlymphoblastic leukemia
20. The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia
21. Improved prospects for long‐term survival in adults with acute myelogenous leukemia
22. Marrow transplantation for acute nonlymphoblastic leukemia in first remission
23. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single‐dose irradiation